Caplight Directory>Investors>Eshelman Ventures>Eshelmanventures


Eshelman Ventures

Eshelman Ventures

Wilmington, North Carolinaeshelmanventures.com

Overview

Eshelman Ventures is an investment company primarily interested in healthcare companies. The firm was founded by Fred Eshelman, who previously founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests. Although Eshelman Ventures concentrates in healthcare, the firm will consider other themes that are attractive and have large potential markets.

Year Founded

2014

Portfolio Companies

7

Investments

CompanyDateStageLead
Incyclix BioApr 2026Series B ExtensionCo-investor
Breakthru MedicineJan 2026Series ACo-investor
Incyclix BioAug 2025Series B ExtensionCo-investor
Paradigm Therapeutics, Inc.Jun 2025Series B ExtensionLead
Paradigm Therapeutics, Inc.May 2025Series BLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersWilmington, North Carolina
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.